Peter de Vries
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Magnetic confinement fusion research 9
-
- T-cell and B-cell Immunology 4
- Co-authors
- Jack W. Singer (6 shared papers)Douglas E. Williams (1 shared paper)Kathleen S. Picha (1 shared paper)Brian Gliniak (1 shared paper)Frederick A. Fletcher (1 shared paper)Ken Brasel (1 shared paper)M. Patricia Beckmann (1 shared paper)Eugene Maraskovsky (1 shared paper)
- Journals
- Fusion Engineering and Design (3 papers)Expert Opinion on Therapeutic Targets (2 papers)Nuclear Fusion (2 papers)Journal of Interferon & Cytokine Research (2 papers)JAMA Network Open (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Peter de Vries
32 papers receiving 1.9k citations
Peter de Vries's Hit Papers
Peers
Comparison fields: 5 of 125
- Hematology 281
- Immunology 308
- Oncology 341
- Nuclear and High Energy Physics 170
- Molecular Biology 762
Countries citing papers authored by Peter de Vries
This map shows the geographic impact of Peter de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter de Vries more than expected).
Fields of papers citing papers by Peter de Vries
This network shows the impact of papers produced by Peter de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter de Vries. The network helps show where Peter de Vries may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter de Vries, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours Hit paper breakdown → | 2017 | 637 |
| 2 | 1993 | 484 | |
| 3 | 2020 | 175 | |
| 4 | 2004 | 137 | |
| 5 | 2014 | 75 | |
| 6 | 2021 | 60 | |
| 7 | 2022 | 58 | |
| 8 | 2003 | 40 | |
| 9 | 2014 | 37 | |
| 10 | 2023 | 36 | |
| 11 | 2006 | 24 | |
| 12 | 2004 | 24 | |
| 13 | 2020 | 23 | |
| 14 | 2022 | 23 | |
| 15 | 2001 | 21 | |
| 16 | 2023 | 20 | |
| 17 | 2011 | 18 | |
| 18 | 2000 | 15 | |
| 19 | 2023 | 13 | |
| 20 | 2019 | 11 |
About Peter de Vries
Peter de Vries is a scholar working on Nuclear and High Energy Physics, Immunology, Biomedical Engineering, Oncology and Infectious Diseases, having authored 33 papers that have together received 2.0k indexed citations. Recurring topics across this work include Magnetic confinement fusion research (9 papers), Superconducting Materials and Applications (7 papers), Fusion materials and technologies (6 papers), T-cell and B-cell Immunology (4 papers), COVID-19 Clinical Research Studies (3 papers), Glycosylation and Glycoproteins Research (3 papers), Protein Degradation and Inhibitors (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Hematology (281 citations), Immunology (308 citations), Oncology (341 citations), Nuclear and High Energy Physics (170 citations) and Molecular Biology (762 citations). Peter de Vries has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Jack W. Singer, Douglas E. Williams, Kathleen S. Picha, Brian Gliniak, Frederick A. Fletcher, Ken Brasel, M. Patricia Beckmann, Eugene Maraskovsky, Terry Farrah and Tim Vanden Bos. Their work appears in journals such as Fusion Engineering and Design, Expert Opinion on Therapeutic Targets, Nuclear Fusion, Journal of Interferon & Cytokine Research and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.